Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) and Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report) are both small-cap medical companies, but which is the better stock? Get Tonix Pharmaceuticals alerts:Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tonix Pharmaceuticals $10.09 million 22.06 -$130.04 million ($20.06) -0.91 Unicycive Therapeutics $680,000.00 221.85 -$36.73 million ($3.95) -1.78ProfitabilityUnicycive Therapeutics has lower revenue, but higher earnings than Tonix Pharmaceuticals. This table compares Tonix Pharmaceuticals and Unicycive Therapeutics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Tonix Pharmaceuticals -963.39% -55.19% -49.89% Unicycive Therapeutics N/A -227.32% -117.71%Analyst RecommendationsThis is a breakdown of current ratings for Tonix Pharmaceuticals and Unicycive Therapeutics, as reported by MarketBeat. Given Unicycive Therapeutics’ stronger consensus rating and higher probable upside, analysts clearly believe Unicycive Therapeutics is more favorable than Tonix Pharmaceuticals.